title: Cutaneous T cell lymphoma cells are targets for immune checkpoint ligand PD-L1-specific, cytotoxic T cells.
authors: Department of Hematology, Center for Cancer Immune Therapy (CCIT), Copenhagen University Hospital, Herlev, Denmark.
authors: S
authors: S
authors: Munir
authors: G H
authors: GH
authors: Andersen
authors: A
authors: A
authors: Woetmann
authors: N
authors: N
authors: Ødum
authors: J C
authors: JC
authors: Becker
authors: M H
authors: MH
authors: Andersen
mesh_terms: D060890:B7-H1 Antigen / Q000276:immunology / Q000378:metabolism*; D005434:Flow Cytometry; D006801:Humans; D016410:Lymphoma, T-Cell, Cutaneous / Q000276:immunology* / Q000378:metabolism / Q000473:pathology; D013602:T-Lymphocytes, Cytotoxic / Q000276:immunology* / Q000378:metabolism
chemical_list: D060890:B7-H1 Antigen; C423236:CD274 protein, human